The 12th edition of iPHEX- International Exhibition for Pharma and Healthcare has opened today at Bharat Mandapam, New Delhi, bringing together India’s pharmaceutical and healthcare ecosystem with global buyers, business delegates and industry stakeholders.
Scheduled from September 7 to 9, 2026, the three-day exhibition is organised by the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) with the support of the Department of Commerce, Ministry of Commerce and Industry. The exhibition has been positioned as an international platform to showcase India’s pharmaceutical products, technologies and healthcare capabilities to global markets.
The 2026 edition features 700+ exhibitors, according to the official event website, alongside 600+ overseas business delegates and 25,000+ expected domestic visitors. The overseas participation includes manufacturers, traders, distributors, importers, agents and other business stakeholders, reinforcing iPHEX’s B2B focus.
The exhibition spans a broad spectrum of the sector, including active pharmaceutical ingredients, finished dosage formulations, bulk drugs and intermediates, excipients, contract manufacturing, biosimilars and vaccines, natural extracts, surgical and wound-care products, animal health, healthcare services, nutraceuticals, vitamins and probiotics.
For the MICE and exhibition industry, iPHEX also underlines the growing role of Bharat Mandapam as a venue for large-scale international B2B exhibitions. With international buyers and Indian manufacturers meeting through focused business interactions, the event is expected to generate significant opportunities for sourcing, partnerships and export-led business.
With its combination of large-scale exhibition infrastructure, international participation and sector-focused business meetings, iPHEX 2026 puts India’s pharma and healthcare capabilities firmly in the global business-events spotlight.